Device Airway Clearance Device

Hillrom - Metaneb System

Payments companies reported to CMS as associated with Hillrom - Metaneb System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1,554associated payments (2023-2025)
59clinicians with associated payments
1company reporting

By year

2023 $492
2024 $478
2025 $584

Payments reported as associated with Hillrom - Metaneb System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Pulmonary Disease $689
Family $136
Physician Assistant $127
Critical Care Medicine (Internal Medicine) $100
Thoracic Surgery (Cardiothoracic Vascular Surgery) $54.75
Nurse Practitioner $52.72

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Hillrom - Metaneb System

These are the largest totals companies reported as associated with Hillrom - Metaneb System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Adel Sandouk Glendora, CA Pulmonary Disease $117.94
Laura Mccauley Appleton, WI Pulmonary Disease $76.68
Jason Ackrivo Philadelphia, PA Pulmonary Disease $56.61
Colin Swenson Atlanta, GA Pulmonary Disease $55.63
John Zeibeq Philadelphia, PA Critical Care Medicine (Internal Medicine) $46.28
Abdul Shahin Brooklyn, NY Physician Assistant $44.60
Jinny Caldentey New Hyde Park, NY Hospice and Palliative Medicine (Internal Medicine) $35.94
Nikolaos Hatzis Bethpage, NY Pulmonary Disease $35.94
Howard Sklarek Southampton, NY Pulmonary Disease $35.94
Wayne Bellucci Riverhead, NY Pulmonary Disease $35.93

Prescribed Hillrom - Metaneb System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.